Microvascular oxygen partial pressure during hyperbaric oxygen in diabetic rat skeletal muscle
AJP Regulatory Integrative and Comparative Physiology
Published online on October 14, 2015
Abstract
Hyperbaric oxygen (HBO) is a major therapeutic treatment for ischemic ulcerations that perforate skin and underlying muscle in diabetic patients. These lesions do not heal effectively, in part, because of the hypoxic microvascular O2 partial pressures (PmvO2) resulting from diabetes-induced cardiovascular dysfunction which alters the dynamic balance between O2 delivery and utilization rates. We tested the hypothesis that HBO in diabetic muscle would exacerbate the hyperoxic PmvO2 dynamics due, in part, to a reduction or slowing of the cardiovascular, sympathetic nervous and respiratory system responses to acute HBO exposure. Adult male Wistar rats were divided randomly into diabetic (DIA: Streptozotocin i.p.) and healthy (CONT) groups. A small animal hyperbaric chamber was pressurized with oxygen (100% O2) to 3.0 ATA at 0.2 ATA/min. Phosphorescence quenching techniques were used to measure PmvO2 in tibialis anterior muscle of anesthetized rats during HBO. Lumbar sympathetic nerve activity (LSNA), heart rate (HR) and respiratory rate (RR) were measured electrophysiologically. During the normobaric hyperoxia and HBO, DIA tibialis anterior PmvO2 increased faster than CONT. Subsequently, PmvO2 remained elevated at similar levels in CONT. Sympathetic nervous system, cardiac and respiratory responses to HBO were slower in DIA versus CONT. HBO treatment increases tibialis anterior muscle PmvO2 more rapidly and for a longer duration in DIA than CONT, but not to a greater level. Whereas, respiratory, cardiovascular and LSNA responses to HBO are profoundly slowed in DIA only the cardiovascular arm (via HR) may contribute to the muscle vascular incompetence and these faster PmvO2 kinetics.